<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<Document>
	<LaunchDetails>
		<LaunchDateComment />
		<NewChemicalEntity />
		<Ingredients>
			<Ingredient>ipratropium bromide</Ingredient>
		</Ingredients>
		<CASIS-USE>
			<CASIS-ACT>
				<Class>
					<ClassCode>R3G</ClassCode>
					<ClassDescription>Anticholinergics Plain and Combinations with
						B2-Stimulants</ClassDescription>
				</Class>
			</CASIS-ACT>
			<CASIS-IND>
				<Indication>Acute exacerbation of chronic bronchitis</Indication>
			</CASIS-IND>
		</CASIS-USE>
		<CASIS-CN>
			<BrandName>IPRABON</BrandName>
		</CASIS-CN>
		<CASIS-CO>
			<CASIS-NORMALIZED-CO>Manufacturer: Zambon</CASIS-NORMALIZED-CO>
			<CASIS-NORMALIZED-CO>ZAMBON GROUP</CASIS-NORMALIZED-CO>
			<Manufacturer>Zambon</Manufacturer>
			<Corporation>ZAMBON GROUP</Corporation>
		</CASIS-CO>
		<CASIS-DSTA>
			<CASIS-NORMALIZED-DSTA>BR: Launched 19980401</CASIS-NORMALIZED-DSTA>
			<Country>Brazil</Country>
			<LaunchDate CCYYMM="19980401">01 Apr 1998</LaunchDate>
		</CASIS-DSTA>
		<CASIS-TX>
			<Biotech>No</Biotech>
			<Unbranded>No</Unbranded>
		</CASIS-TX>
		<CASIS-RN>
			<CASInfo>
				<CASItem />
			</CASInfo>
		</CASIS-RN>
	</LaunchDetails>
	<PackInfo>
		<ExcipientInfo>
			<Excipient />
		</ExcipientInfo>
		<PriceInfo>
			<Price>liquid inhalation 20 ml 1: BRL 4.370 (RPP)</Price>
		</PriceInfo>
		<DoseFormInfo>
			<DoseForm>liquid inhalation</DoseForm>
		</DoseFormInfo>
		<NumberOfIngredients>1</NumberOfIngredients>
		<CASIS-TX>
			<CompositionInfo>
				<Composition>liquid inhalation: ipratropium bromide, 0.025%</Composition>
			</CompositionInfo>
		</CASIS-TX>
	</PackInfo>
	<LaunchStatus>
		<RecordStatus />
	</LaunchStatus>
	<CASIS-MDNUMBER>MD000001</CASIS-MDNUMBER>
</Document>